Search results for "patient"

'A Hellish Time': Chronic Ear Disorder Forces IU to Postpone Concert Tour and Album Release

'A Hellish Time': Chronic Ear Disorder Forces IU to Postpone Concert Tour and Album Release

Singer and actor IU, 33, has postponed her upcoming September concert tour and the release of her sixth full-length album following a worsening of...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells and deliver targeted radiation.
Blood Sugar Control After Stomach Cancer Surgery Varies Sharply by Intestinal Reconstruction Method

Blood Sugar Control After Stomach Cancer Surgery Varies Sharply by Intestinal Reconstruction Method

For patients navigating both stomach cancer and type 2 diabetes, the surgical method used to reconnect the digestive...
50 Years After Its Discovery, Legionnaires’ Disease Remains a Summer Threat as Cooling Systems Hum

50 Years After Its Discovery, Legionnaires’ Disease Remains a Summer Threat as Cooling Systems Hum

As sweltering heat waves and high humidity force air conditioners and cooling equipment to run continuously, public...

"1 Million Won a Month Covers Everything"? The Hidden Cost Trap in Long-Term Senior Care

"If you pay in the 1 million won-a-month range, we’ll take care of everything." It is a familiar sales pitch at many...
Placebo Outperforms TG-C: Data Errors and Stock Volatility Cloud Kolon TissueGene’s Phase 3 Trial

Placebo Outperforms TG-C: Data Errors and Stock Volatility Cloud Kolon TissueGene’s Phase 3 Trial

Kolon TissueGene’s knee osteoarthritis cell and gene therapy, TG-C, has failed to achieve statistical significance on...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
EZH1 Mutation 'Locks' Cancer-Fighting Genes to Fuel Thyroid Tumors, Study Finds

EZH1 Mutation 'Locks' Cancer-Fighting Genes to Fuel Thyroid Tumors, Study Finds

Cancer cells do not grow simply by switching on genes that drive proliferation; they can also lock away genes that keep...
Korea University Anam Hospital Logs 8,000 Atrial Fibrillation Procedures, a First in South Korea

Korea University Anam Hospital Logs 8,000 Atrial Fibrillation Procedures, a First in South Korea

Korea University Anam Hospital has achieved a cumulative total of 8,000 atrial fibrillation procedures—a nationwide...
Korea’s Healthcare Paradox: Near-Bottom Physician Ranks Meet Top-Tier Life Expectancy

Korea’s Healthcare Paradox: Near-Bottom Physician Ranks Meet Top-Tier Life Expectancy

Hospital waiting rooms across South Korea are perpetually packed, where a 30-minute wait remains a routine part of any...